文献速递慢性肾脏病水电解质与酸碱

静脉pH调节低碳酸氢盐血症与新发肾衰竭需替代治疗的关联:队列研究

Modulation of the Association of Hypobicarbonatemia and Incident Kidney Failure With Replacement Therapy by Venous pH: A Cohort Study.
PubMed 文献 · Am J Kidney Dis · 2020-08-21

该回顾性队列研究纳入1058例eGFR<60mL/min/1.73m2的日本患者,发现静脉pH可修饰基线碳酸氢盐水平与KFRT风险的关联。在酸血症(pH<7.32)患者中,最低(vs最高)碳酸氢盐四分位与KFRT风险增加2.29倍(95%CI 1.10-4.77;P=0.03)相关;而无酸血症(pH≥7.32)患者中无显著关联。

要点

  • 静脉pH修饰碳酸氢盐与KFRT的关联(交互P=0.04)。
  • 酸血症患者中,低碳酸氢盐与KFRT风险独立相关。
  • 无酸血症患者中,碳酸氢盐与KFRT无显著关联。

核心结论

  • 静脉pH修饰低碳酸氢盐血症与慢性肾脏病进展至KFRT的关联。

研究设计与样本

  • 回顾性队列研究,纳入1058例eGFR<60mL/min/1.73m2的日本患者。

主要发现

  • 中位随访3.0年,374例发生KFRT;碳酸氢盐最低四分位(≤21.5 mEq/L)中59%有酸血症(pH<7.32),38%pH正常,3%碱血症(pH>7.42)。
  • 酸血症(pH<7.32)患者中,最低(vs最高)碳酸氢盐四分位与KFRT风险增加2.29倍相关(95%CI 1.10-4.77;P=0.03)。
  • 无酸血症(pH≥7.32)患者中,碳酸氢盐与KFRT无显著关联;交互作用P=0.04。
  • 探索性分析:呼吸代偿能力每增加0.1,KFRT风险降低(HR 0.90;95%CI 0.87-0.94;P<0.001)。

临床怎么用

  • 测量静脉pH可能有助于识别低碳酸氢盐血症且KFRT风险较高的CKD患者。
  • 静脉pH可能为低碳酸氢盐血症患者的治疗提供参考信息。

局限性

  • 观察性研究设计。
  • 血气测量在特定患者人群中进行。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Studies showing an association between lower bicarbonate levels and worse kidney disease prognosis have not accounted for the influence of pH. It remains unknown whether this association is consistent across a wide range of blood pH values. This study sought to assess how pH modifies the relationship between hypobicarbonatemia and incident kidney failure requiring kidney replacement therapy (KFRT). STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: 1,058 Japanese patients with estimated glomerular filtration rates<60mL/min/1.73m2. EXPOSURE: Baseline venous bicarbonate levels and venous pH. OUTCOME: KFRT defined as initiation of kidney replacement therapy (hemodialysis, peritoneal dialysis, and kidney transplantation). ANALYTICAL APPROACH: Cox proportional hazards model assessing the interaction between baseline bicarbonate levels and venous pH on incident KFRT. RESULTS: In the lowest bicarbonate quartile (≤21.5 mEq/L), 59% of patients had acidemia (pH<7.32), whereas 38% had venous pH within the normal range and 3% had alkalemia (pH>7.42). During a median follow-up of 3.0 years, 374 patients developed KFRT. Venous pH modified the association between bicarbonate level and rate of KFRT (P for interaction=0.04). After adjustment for potential confounders, including capacity for respiratory compensation, the lowest (vs the highest) bicarbonate quartile was associated with a 2.29-fold (95% CI, 1.10-4.77; P=0.03) higher rate of KFRT among patients with acidemia (pH<7.32). In contrast, among patients without acidemia (pH≥7.32), no significant association was found between bicarbonate level and KFRT. In an exploratory analysis, patients with higher respiratory compensation capacity had a lower rate of KFRT (HR per 0.1 increase in respiratory compensation capacity, 0.90; 95% CI, 0.87-0.94; P<0.001). LIMITATIONS: Observational study design; blood gas measurements were performed in a select patient population. CONCLUSIONS: Venous pH modified the association of hypobicarbonatemia with progression of chronic kidney disease to KFRT. Measurement of venous pH may be valuable for identifying patients with chronic kidney disease and hypobicarbonatemia and may inform treatment.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Kajimoto S, Sakaguchi Y, Asahina Y, et al. Modulation of the Association of Hypobicarbonatemia and Incident Kidney Failure With Replacement Therapy by Venous pH: A Cohort Study. Am J Kidney Dis. 2020. PMID: 32828983. doi:10.1053/j.ajkd.2020.06.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。